Terms: = Pancreatic cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Diagnosis
44 results:
1. EUS-guided tissue acquisition in patients with solid pseudopapillary neoplasms of the pancreas.
Jiménez-Gutiérrez JM; de la Mora-Levy JG; Alonso-Lárraga JO; Hernández-Guerrero AI; Soriano-Herrera BA; Villegas-González LF; Uscanga-Domínguez LF; López-Romero S; Téllez-Ávila FI
Postgrad Med; 2024 Jan; 136(1):78-83. PubMed ID: 38315145
[TBL] [Abstract] [Full Text] [Related]
2.
Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract] [Full Text] [Related]
4. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with
Watabe T; Kabayama K; Naka S; Yamamoto R; Kaneda K; Serada S; Ooe K; Toyoshima A; Wang Y; Haba H; Kurimoto K; Kobayashi T; Shimosegawa E; Tomiyama N; Fukase K; Naka T
J Nucl Med; 2023 Dec; 64(12):1949-1955. PubMed ID: 37827841
[TBL] [Abstract] [Full Text] [Related]
5. Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer.
Khojasteh-Leylakoohi F; Mohit R; Khalili-Tanha N; Asadnia A; Naderi H; Pourali G; Yousefli Z; Khalili-Tanha G; Khazaei M; Maftooh M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Shahidsales S; Lam AK; Giovannetti E; Nazari E; Batra J; Avan A
Sci Rep; 2023 Oct; 13(1):16678. PubMed ID: 37794108
[TBL] [Abstract] [Full Text] [Related]
6.
Ma XK; Liu TL; Ren YN; Ma XP; Yao Y; Hou XG; Ding J; Wang F; Huang HF; Zhu H; Yang Z
Acta Pharmacol Sin; 2024 Feb; 45(2):436-448. PubMed ID: 37749238
[TBL] [Abstract] [Full Text] [Related]
7. Clinical application of Al
Lyu Z; Han W; Zhang Q; Zhao H; Liu S; Wang Y; He J; Zhao C; Tian L; Fu P
Cancer Imaging; 2023 Sep; 23(1):86. PubMed ID: 37700343
[TBL] [Abstract] [Full Text] [Related]
8. Tumor Characterization by [
Rasinski P; Af Burén S; Holstensson M; Nilsson T; Loizou L; Tran TA; Sparrelid E; Löhr JM; Axelsson R
J Nucl Med; 2023 Aug; 64(8):1232-1237. PubMed ID: 37348917
[TBL] [Abstract] [Full Text] [Related]
9. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
10. The added value of [
Liu Q; Shi S; Liu S; Xu X; Hu S; Zhang J; Wang C; Yu X; Song S
Eur Radiol; 2023 Jul; 33(7):5007-5016. PubMed ID: 36809431
[TBL] [Abstract] [Full Text] [Related]
11. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [
Chen R; Yang X; Yu X; Zhou X; Ng YL; Zhao H; Li L; Huang G; Zhou Y; Liu J
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):929-936. PubMed ID: 36334106
[TBL] [Abstract] [Full Text] [Related]
12. PET Imaging of Fibroblast Activation Protein in Various Types of cancer Using
Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
[TBL] [Abstract] [Full Text] [Related]
13. A dual meta-learning framework based on idle data for enhancing segmentation of pancreatic cancer.
Li J; Qi L; Chen Q; Zhang YD; Qian X
Med Image Anal; 2022 May; 78():102342. PubMed ID: 35354108
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of the diagnostic efficacy of
Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
[TBL] [Abstract] [Full Text] [Related]
15. Weight Tracking as a Novel Prognostic Marker After Pancreatectomy.
Hue JJ; Ocuin LM; Kyasaram RK; Shanahan J; Rao G; Rothermel LD; Ammori JB; Hardacre JM; Winter JM; Markt SC
Ann Surg Oncol; 2022 Jun; 29(6):3450-3459. PubMed ID: 35067790
[TBL] [Abstract] [Full Text] [Related]
16. Detection of pancreatic cancer by convolutional-neural-network-assisted spontaneous Raman spectroscopy with critical feature visualization.
Li Z; Li Z; Chen Q; Ramos A; Zhang J; Boudreaux JP; Thiagarajan R; Bren-Mattison Y; Dunham ME; McWhorter AJ; Li X; Feng JM; Li Y; Yao S; Xu J
Neural Netw; 2021 Dec; 144():455-464. PubMed ID: 34583101
[TBL] [Abstract] [Full Text] [Related]
17. PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis.
Husmann L; Muehlematter UJ; Grimm F; Ledergerber B; Messerli M; Kudura K; Gruenig H; Muellhaupt B; Hasse B; Huellner MW
Parasitol Int; 2021 Aug; 83():102356. PubMed ID: 33872794
[TBL] [Abstract] [Full Text] [Related]
18. Borderline Resectable and Locally Advanced pancreatic cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
[No Abstract] [Full Text] [Related]
19. Long-term health-related quality of life in persons diagnosed with an insulinoma in Finland 1980-2010.
Peltola E; Hannula P; Huhtala H; Sintonen H; Metso S; Sand J; Laukkarinen J; Tiikkainen M; Schalin-Jäntti C; Sirén J; Soinio M; Nuutila P; Moilanen L; Ebeling T; Jaatinen P
Clin Endocrinol (Oxf); 2021 Feb; 94(2):250-257. PubMed ID: 32974918
[TBL] [Abstract] [Full Text] [Related]
20. Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells.
Bourdi M; Rudloff U; Patnaik S; Marugan J; Terse PS
Regul Toxicol Pharmacol; 2020 Oct; 116():104716. PubMed ID: 32619635
[TBL] [Abstract] [Full Text] [Related]
[Next]
